Preventing disease through opportunistic, rapid engagement by primary care teams using behaviour change counselling (PRE-EMPT): protocol for a general practice-based cluster randomised trial

BMC Family Practice

Study Protocol

Laurence Moore¹  Hazel Thornton²  Adrian Edwards³  Chris C Butler³  Fiona Wood³  Stephen Rollnick³  Ben Carter⁴  Jim McCambridge⁵  David Cohen⁶  Christine Smith⁷  Claire Lane⁸  Sharon A Simpson⁹  Clio Spanou⁹  Timothy Pickles⁹  Kerry Hood⁹  Elizabeth Randell⁹ 

[1] Cardiff Institute of Society and Health, School of Social Sciences, Cardiff University, 1-3 Museum Place, CF10 3BD, Cardiff, UK;Department of Health Sciences, 2nd Floor Adrian Building, University of Leicester, LE1 7RH, Leicester, UK;Department of Primary Care and Public Health, School of Medicine, Cardiff University, Neuadd Meirionnydd, Heath Park, CF14 4XN, Cardiff, UK;Department of Public Health, Epidemiology & Biostatistics, University of Birmingham, B15 2TT, Edgbaston, Birmingham, UK;Department of Social & Environmental Health Research, London School of Hygiene & Tropical Medicine, 15 - 17 Tavistock Place, WC1H 9SH, London, UK;Health Economics and Policy Research Unit, Faculty of Health Sport and Science, University of Glamorgan, CF37 1DL, Pontypridd, UK;School of Nursing and Midwifery Studies, Cardiff University, Ty Dewi Sant, Heath Campus, CF14 4XN, Cardiff, UK;School of Psychology, University of Birmingham, B15 2TT, Edgbaston, Birmingham, UK;South East Wales Trials Unit, School of Medicine, Cardiff University, Neuadd Meirionnydd, Heath Park, CF14 4XN, Cardiff, UK;

关键词: Motivational Interview;    Varenicline;    Sibutramine;    Blended Learning;    Motivational Interview;   

DOI  :  10.1186/1471-2296-11-69

 received in 2010-07-13, accepted in 2010-09-21,  发布年份 2010

来源: Springer

【 摘 要 】

BackgroundSmoking, excessive alcohol consumption, lack of exercise and an unhealthy diet are the key modifiable factors contributing to premature morbidity and mortality in the developed world. Brief interventions in health care consultations can be effective in changing single health behaviours. General Practice holds considerable potential for primary prevention through modifying patients' multiple risk behaviours, but feasible, acceptable and effective interventions are poorly developed, and uptake by practitioners is low. Through a process of theoretical development, modeling and exploratory trials, we have developed an intervention called Behaviour Change Counselling (BCC) derived from Motivational Interviewing (MI). This paper describes the protocol for an evaluation of a training intervention (the Talking Lifestyles Programme) which will enable practitioners to routinely use BCC during consultations for the above four risk behaviours.Methods/DesignThis cluster randomised controlled efficacy trial (RCT) will evaluate the outcomes and costs of this training intervention for General Practitioners (GPs) and nurses. Training methods will include: a practice-based seminar, online self-directed learning, and reflecting on video recorded and simulated consultations. The intervention will be evaluated in 29 practices in Wales, UK; two clinicians will take part (one GP and one nurse) from each practice. In intervention practices both clinicians will receive training. The aim is to recruit 2000 patients into the study with an expected 30% drop out. The primary outcome will be the proportion of patients making changes in one or more of the four behaviours at three months. Results will be compared for patients seeing clinicians trained in BCC with patients seeing non-BCC trained clinicians. Economic and process evaluations will also be conducted.DiscussionOpportunistic engagement by health professionals potentially represents a cost effective medical intervention. This study integrates an existing, innovative intervention method with an innovative training model to enable clinicians to routinely use BCC, providing them with new tools to encourage and support people to make healthier choices. This trial will evaluate effectiveness in primary care and determine costs of the intervention.Trial RegistrationISRCTN22495456

【 授权许可】

CC BY   
© Spanou et al; licensee BioMed Central Ltd. 2010